Sharekhan

Biofil Chemicals and Pharmaceuticals Ltd

Fri 30/05/2025,15:53:37 NSE: BIOFILCHEM

₹ 49.24 -1.61 (-3.17%)
BUY NOW Buy Biofil Chemicals and Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Biofil Chemicals and Pharmaceuticals Ltd

Fri 30/05/2025,16:1:0

Biofil Chemicals and Pharmaceuticals Ltd

Fri 30/05/2025,15:53:37 | NSE : BIOFILCHEM

₹ 49.24-1.61 (-3.17%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 51.56

Previous Close

₹ 50.85

Volume

48996

Mkt Cap ( Rs. Cr)

₹80.13

High

₹ 51.56

Low

₹ 48.05

52 Week High

₹ 91.87

52 Week Low

₹ 40.40

Book Value Per Share

₹ 11.53

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Biofil Chemicals and Pharmaceuticals Ltd

Your Vote -

Buy

39.06%

Hold

7.81%

Sell

53.13%

39.06%

64 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Biofil Chemicals and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Biofil Chemicals Q4 net profit down 20.00% at Rs 0.20 cr

    30 May 2025, 7:06PM The company reported standalone net profit of Rs 0.20 crore for the quarter ended March 31, 2025 as compared to Rs 0.25 crore in the same period last

  • Biofil Chemicals - Outcome of Board Meeting

    30 May 2025, 6:52PM Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Biofil Chemicals - Audited Financial Result For The Financial Year Ended 31.03.2025

    30 May 2025, 6:36PM Audited Financial Result for the Financial Year ended 31.03.2025

  • Biofil Chemicals - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 30Th May, 2025 Pursuant To Regulation 30

    30 May 2025, 6:29PM Outcome of Board Meeting held on Friday 30th May, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations

  • Biofil Chemicals - Board Meeting Intimation

    22 May 2025, 4:03PM BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly

  • Biofil Chemicals - Board Meeting Intimation for Intimation For Meeting Of Board Of The Directors (Serial No.02/2025-26) Of Th

    22 May 2025, 3:27PM Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter ali

  • Biofil Chemicals - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    22 Apr 2025, 2:57PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Biofil Chemicals - Disclosure of material issue

    19 Apr 2025, 3:21PM Biofil Chemicals & Pharmaceuticals Limited has informed regarding Disclosure of material issue

  • Biofil Chemicals - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    19 Apr 2025, 3:16PM BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/

  • Biofil Chemicals - Change in Management

    19 Apr 2025, 3:15PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about change in Management

  • Biofil Chemicals - Change in Company Secretary/Compliance Officer

    19 Apr 2025, 3:14PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

  • Biofil Chemicals - Announcement Under Regulation 30 (5) Of SEBI (LODR) Regulation , 2015

    19 Apr 2025, 3:08PM Appointment of Mr. Apoorv Jain ACS (71739) as Company Secretary and Compliance Officer of the Company.

  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    19 Apr 2025, 2:56PM Appointment of Mr. Apoorv Jain (ACS) 71739 as a Company Secretary and Compliance Officer of the company w.e.f. 19th April, 2025.

  • Biofil Chemicals - Appointment of Company Secretary and Compliance Officer

    19 Apr 2025, 2:50PM Appointment of Mr. Apoorv Jain as Company Secretary (KMP) and Compliance Officer of the Company.

  • Biofil Chemicals has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    12 Apr 2025, 7:00PM As of March 2025, 46.82% is owned by Indian Promoters and 53.18% by Public. <p align=justify> Top five Promoters holding highest number of shares of B

  • Biofil Chemicals - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    5 Apr 2025, 11:41AM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Biofil Chemicals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Apr 2025, 11:38AM Certificate for Regulation 74(5) of Securities and Exchange Board of India(Depository Participants) Regulation, 2018 for the quarter end 31st March, 2

  • Biofil Chemicals - Trading Window-XBRL

    25 Mar 2025, 2:54PM BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window

  • Biofil Chemicals - Trading Window

    25 Mar 2025, 2:52PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tra

  • Biofil Chemicals - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    24 Mar 2025, 11:59AM BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/

  • Biofil Chemicals - Change in Management

    22 Mar 2025, 6:22PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about change in Management

  • Biofil Chemicals - Shareholders meeting

    22 Mar 2025, 3:03PM Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    22 Mar 2025, 4:09PM Confirmation of appointment of Meet Shah DIN 06578351 from Additional director to director undet the catagory of non executive non independent directo

  • Biofil Chemicals - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    22 Mar 2025, 2:51PM Submission of voting results of postal ballot and report of scrutinizer

  • Biofil Chemicals - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    11 Mar 2025, 5:41PM BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/

  • Biofil Chemicals - Change in Management

    11 Mar 2025, 5:38PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about change in Management

  • Biofil Chemicals - Demise

    11 Mar 2025, 5:33PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr Ramesh Shah, Chairman & Managing Director of the company o

  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Demise

    11 Mar 2025, 5:22PM Disclosure under Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Regulations, 2015- Intimation of Sudden demise of Mr. Ramesh Shah (

  • Biofil Chemicals - Announcement under Regulation 30 (LODR)-Change in Management

    11 Mar 2025, 5:20PM Disclosure under Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Regulations, 2015- Intimation of Sudden demise of Mr. Ramesh Shah (
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Biofil Chemicals and Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 18.6417 17.8268 17.3024 16.5589 16.0751
Liabilities 18.6417 17.8268 17.3024 16.5589 16.0751
Equity 16.2738 16.2738 16.2738 16.2738 16.2738
Gross Profit 0.8165 1.1676 1.3327 1.5991 1.8223
Net Profit 0.7092 0.5604 0.6984 1.2414 1.2072
Cash From Operating Activities 2.3937 -0.1118 -0.2199 1.1109 0.8932
NPM(%) 1.77 1.86 3.12 3.47 4.06
Revenue 40.0353 30.0352 22.3823 35.7504 29.6902
Expenses 39.2188 28.8676 21.0496 34.1513 27.8679
ROE(%) 3.78 2.98 3.72 6.61 6.43

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Biofil Chemicals and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.25 -0.44 26.62 28.27 301.39 0.62
Lotus Eye Hospital and Institute Ltd 71.90 -0.18 205.43 103.00 3.55 0.00
Vaishali Pharma Ltd 12.69 -0.16 211.50 53.09 3.13 0.00
Astec Lifesciences Ltd 672.20 -0.91 0.00 97.12 -687.10 0.00

Company Info

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

Read More

Parent Organisation

Biofil Chemicals & Pharmaceuticals Ltd.

Founded

04/01/1985

Managing Director

Mr.Ramesh Shah

NSE Symbol

BIOFILCHEMEQ

FAQ

The current price of Biofil Chemicals and Pharmaceuticals Ltd is ₹ 49.24.

The 52-week high for Biofil Chemicals and Pharmaceuticals Ltd is ₹ 51.56 and the 52-week low is ₹ 48.05.

The market capitalization of Biofil Chemicals and Pharmaceuticals Ltd is currently ₹ 80.13. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Biofil Chemicals and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Biofil Chemicals and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Biofil Chemicals and Pharmaceuticals Ltd shares.

The CEO of Biofil Chemicals and Pharmaceuticals Ltd is Mr.Ramesh Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT